Risk of fatal pulmonary events in patients with advanced non-small-cell lung cancer treated with EGF receptor tyrosine kinase inhibitors: a comparative meta-analysis
2012 ◽
Vol 12
(11)
◽
pp. 1429-1435
◽
2010 ◽
Vol 26
(2)
◽
pp. 424-431
◽
2019 ◽
Vol 7
(18)
◽
pp. 452-452
◽
Keyword(s):